Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CRNX · against 163 other Healthcare companies of similar size
Ranked #9 of 164 · scores higher than 94% of peers
Bars: peers in each 10-point band of the growth score21 peers with a growth score of 90–100, including CRNX · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | CRNX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 164 reported | 640.7% | 10.2% | 99% | 33% | |
| Earnings per share growthHigher is better · 117 reported | Not reported | 12.4% | — | — | 33% |
| 3-year revenue growthHigher is better · 158 reported | 17.6% | 10.8% | 75% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 9.3B USD | 98 | 64 | |
| 4 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 4 | 7.3B USD | 97 | 74 | |
| 6 | 16.5B USD | 96 | 37 | |
| 6 | 14.5B USD | 96 | 30 | |
| 6 | 5.7B USD | 96 | 52 | |
| 9 | 9.0B USD | 95 | 51 | |
| 9 | 4.7B USD | 95 | 42 | |
| 11 | 71.0B HKD (≈$9.1B) | 94 | 54 | |
| 11 | 10.5B USD | 94 | 56 | |
| 13 | 9.4B USD | 93 | 70 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score